MedTrace Logo

Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

NCT07203482 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-10-02

No results posted yet for this study

Summary

Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this research database is to prospectively collect data to assess treatment related complications, oncologic outcomes and urinary/sexual function, and identify predictors of complications, oncological control and functional outcomes after Hhigh-intensity focused ultrasound (HIFU) ablation of prostate cancer with the intent to guide further research and improve patient care. We will include subjects who will have a HIFU procedure performed from all Sub-Investigators included in the study.

Conditions

Sponsors & Collaborators

Principal Investigators

  • James Wysock, MD · NYU Langone Health

Eligibility

Min Age
40 Years
Max Age
95 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2030-12-31
Completion
2050-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07203482 on ClinicalTrials.gov